repurposed propranolol (Texas Tech University/Harvard Medical School/Anticancer Fund/GlobalCures)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namerepurposed propranolol (Texas Tech University/Harvard Medical School/Anticancer Fund/GlobalCures)
Drug Alias Namepropranololrepurposed propranolol (Harvard Medical School/Anticancer Fund/GlobalCures)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsHemangiosarcomaSarcomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesTexas Tech University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTexas Tech UniversityGlobalCuresHarvard Medical School +[4] 
Active IndicationsN/A
Inactive IndicationsHemangiosarcomaSarcomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A